Livedo reticularis

 

Salient features

 

Livedo reticularis (ILR) is a mottled bluish (Iivid) discoloration of the skin that occurs in a net-like pattern. It is not a diagnosis in itself but a reaction pattern.

 

Classification distinguishes between:

·       Idiopathic livedo reticularis (ILR): A purple/livid discoloration of the skin in a netlike pattern disappearing after warming. It is a physiologic phenomenon. (Synonym: cutis marmorata).

·       Secondary (symptomatic) livedo reticularis (SLR): A purple discoloration occurring in a starburst or lightning-like pattern, netlike but with open (not annular) meshes; mostly, but not always, confined to the lower extremities and buttocks. It is a reaction pattern often indicative of serious systemic disease. (Synonym: livedo racemosa).

·       Sneddon syndrome is a potentially life-threatening disease occurring more often in women than in men and manifesting in the skin as SLR and in the CNS as transient ischemic attacks and cerebrovascular insults. May be associated with livedoid vasculitis with ulcerations on ankles and acrally.

·       Management: No treatment necessary for ILR; for SLR, keep from chilling, pentoxifylline, low-dose aspirin, and heparin.

 

 

Definition

 

Livedo is an ischemic dermopathy characterized by mottled, cyanotic discoloration (lacelike pattern) on the surface of the skin created by low blood flow through the cutaneous microvasculature system.

 


Epidemiology

 

Livedo reticularis is typically a primary disorder that affects young to middle-aged females (20-50 years of age) who are otherwise healthy. The epidemiological factors of livedo racemosa are dependent on the underlying condition. It is the most frequent dermatological manifestation in patients with antiphospholipid syndrome, present in 25% of patients with primary APS and in up to 70% of patients with SLE-associated APS.

 

Pathogenesis

 


LR results from alterations in blood flow through the cutaneous microvasculature system. The latter consists of arterioles that are oriented perpendicularly to the skin surface. The vessels then divide into capillary beds that in turn drain into a subpapillary plexus. It has been proposed that this arrangement of vessels gives rise to a series of cones, the bases of which measure 1–4 cm in diameter and lie on the skin's surface with the ascending arteriole at the apex of each cone. At the edge of the cone, the venous plexus is more prominent and the arterial bed is diminished. Any process that reduces blood flow through the feeding arterioles will result in the accumulation of deoxygenated blood in the venous plexus produces a cyanotic network pattern on the skin which is livedo reticularis. Diminished arterial flow can result from vasospasm, hyper viscosity and/or thrombosis. Physiological arterial vasospasm produces the reversible cutaneous discoloration of livedo reticularis. Livedo reticularis can occur as a physiological reaction to cold exposure and disappears with warming, when it is known as Cutis marmorata. Protracted arteriolar vasospasm, hyper viscosity and/or thrombosis underlie the pathologic skin changes of livedo recemosa.

Livedo vasculopathy is a rare ulcerative subtype of livedo racemosa due to fibrinolytic abnormalities and microcirculatory thrombosis.


 


 

 

·        

·        

 

 



 

Clinical features

 

History


With the exception of a subjective feeling of coldness, the majority of patients with livedo reticularis are asymptomatic. Patients often present with concerns regarding their skin discoloration. A minority describes mild pain and numbness. The symptoms are worse during winter months. Livedo racemosa-associated symptoms are related to the causative secondary disorder.

 

Cutaneous lesions

 

In livedo reticularis, a symmetric fishnet-like red or purple mottling surrounds a pallorous conical core. This discoloration is aggravated by cold exposure and may completely dissipate with warming. The livedo rings are most pronounced on the lower limbs, but the abdomen and upper limbs may also be affected.

In contradistinction to symmetric and uniform patter of livedo reticularis, the discoloration of livedo racemosa is asymmetric, irregular, and “broken”. Although it may improve with warming, it does not resolve completely. Attendant skin manifestation of livedo racemosa may include purpura, nodules, macules, ulcerations and/or atrophic blanch- type scarring. When associated with livedoid vasculitis, ulceration develops. In livedoid vasculitis, classical triad is livedo racemosa, recurrent painful small punched-out ulcers that have a very poor tendency for healing followed by atrophic blanch- type scars that occurs on the dorsum of forefoot, ankles and lower legs distributed symmetrically.

In both livedo reticularis and livedo racemosa, the skin is palpably cool.

 


Laboratory tests

 

In livedo reticularis laboratory testing is typically negative and consequently is unwarranted. An APA panel should be obtained on all patients presenting with livedo racemosa. Typical investigations would include a thrombophilia screen, autoimmune screen, full blood count, metabolic panel and serum protein electrophoresis. Further investigations such as ultrasound and echocardiography may be required to look for sources of emboli.

A skin biopsy is not required in livedo reticularis as the findings are nonspecific. A large punch or wedge biopsy of the deep reticular dermis and subcutaneous fat is sometimes helpful in identifying the secondary cause of livedo racemosa. In skin biopsies it is necessary to sample the affected arterioles and should be performed from both the central blanched areas and the purplish livedo areas to increase the diagnostic yield as changes may be present in either or both areas.

 

Diagnosis


The diagnosis of livedo is easily made by identifying the characteristic mottled skin discoloration. It is paramount that the clinician distinguishes between livedo reticularis and livedo racemosa. Once diagnosis of livedo racemosa is established, the secondary cause should be sought by appropriate clinical laboratory tests. Diagnostic difficulties may occur when no other pathological signs except livedo racemosa are found. This clinical condition, known as “idiopathic livedo racemosa”, may represent a very early stage of sneddon syndrome.

 


Condition associated with  livedo Racemosa

·       Antiphospholipid antibody syndrome

·       Sneddon syndrome

·       Livedoid vasculopathy

·       Medications (e.g. amantadine, norepinephrine, interferon)

·       Vasculitis (especially polyarteritis nodosa)

·       Collagen vascular diseases

·       Myeloprolifeartive syndromes (Polycythemia vera, essential thrombocytosis)

·       Paraproteinemias

·       Cryoglobulinemia/ Cryofibrinogenemia/ Cold agglutinin disease

·       Atheroembolic disease

·       Calciphylaxis

·       Hyperoxaluria

·       Atrial myxoma

·       Erythema abigne

·       Chronic pancreatitis

·       Infections (e.g. hepatitis C [vasculitis], Mycoplasma spp. [cold agglutinins], syphilis)


 

Prognosis and clinical course

 

The prognosis for livedo reticularis is excellent as this is primarily a cosmetic condition. Livedo racemosa associated prognosis is less favorable and parallels the associated disease. Of interest, livedo racemosa has been identified as a marker for predicting multiple thromboses in the APAS. Additionally, up to 40% of patients manifest livedo racemosa as the initial sign of the APAS. In addition, increased rate of pregnancy loss has been recognized in patients with widespread livedo racemosa who were negative for antiphopholipid antibodies, suggesting that livedo racemosa may be an independent risk factor for pregnancy loss in the absence of APS.

 

Treatment


Other than cold avoidance, medical treatment of primary LR is typically unwarranted. The symptoms may improve spontaneously with age.

Therapy of livedo racemosa should be directed towards the underlying disorder. Patients with livedo racemosa and the APAS with thrombosis require anticoagulation.

 

 

 

 

 

Popular Posts